Re: Additional Reports Of Exempt Distribution.

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

fuzzyjr

Rank: Vice President [?]

Points: 5237 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Additional Reports Of Exempt Distribution.

in response to

Re: Additional Reports Of Exempt Distribution.

fouremm

posted on Jun 06, 2024 10:20AM

Thanks fouremm , that gives greater clarification & may also mean the light is still green for something to take place prior to the AGM imo.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply